How Long Does It Take for an Occipital Nerve Block to Work?

Most people feel meaningful pain relief from an occipital nerve block within about 20 to 30 minutes of the injection. A meta-analysis of patients with acute headaches found a roughly 40 to 45 percent reduction in pain scores within 20 minutes, and the effect tends to strengthen over the next half hour. But the first few minutes after the needle are often anticlimactic, and the longer-term picture of how the block performs over days and weeks is more variable than most patients expect.

What the First 30 Minutes Actually Look Like

The timeline breaks down into a fast phase and a slightly slower buildup. In the first five to 15 minutes, you probably won’t notice much. A meta-analysis focused specifically on acute migraine found no statistically significant difference in pain scores between patients who received a greater occipital nerve block and those who received a control treatment during the first zero to 15 minutes after injection.¹ The local anesthetic needs time to diffuse through the surrounding tissue and reach the nerve fibers, so this lag is expected and not a sign that the block failed.

By around 15 minutes, things start to shift. A separate systematic review of peripheral nerve blocks for primary headaches found pain scores significantly lower than placebo at the 15-minute mark.² And by 30 minutes, the difference becomes clearer. The acute migraine meta-analysis that showed no significant effect at 15 minutes found a meaningful drop in pain scores at 30 minutes and an even stronger effect at 45 to 60 minutes.¹ An emergency department trial comparing the block against an anti-inflammatory drug and a placebo showed statistically significant differences at 30 and 45 minutes.³

So the practical answer: don’t judge the block during those first 10 minutes in the clinic. The sweet spot for knowing whether it’s working tends to arrive around 20 to 30 minutes after the injection.⁴ One early sign your provider may check for is numbness in the skin on the back of your scalp, which confirms the anesthetic reached the right nerve territory.⁵

Why There’s a Delay at All

The greater occipital nerve runs through dense tissue at the back of your head, and its exact path varies from person to person. In a cadaver study, the nerve simply passed along the outer edge of the trapezius muscle in about 63 percent of specimens, but in the remaining 37 percent it actually pierced through the muscle itself.⁶ That anatomical variability means the injected medication sometimes needs more time to soak through layers of muscle and fascia before it reaches a high enough concentration around the nerve to shut down pain signaling.

There’s also a reason the block can help with headaches that seem to come from places far from the back of the skull. Research using brain imaging has shown that blocking the occipital nerve dampens pain-processing activity in the trigeminocervical complex, a relay station in the upper spinal cord where signals from the occipital nerve converge with signals from the face and forehead.⁷ That convergence explains why numbing one nerve at the back of the head can reduce migraine pain you feel behind your eye. But because the relief depends on a cascade of downstream changes in central pain processing, it takes longer than just numbing skin.

How Long the Relief Typically Lasts

The local anesthetic itself wears off within hours. But for many patients, the pain relief extends well beyond that, often lasting weeks. A review of greater occipital nerve blocks for chronic migraine prevention found that the benefit from a single injection lasted up to four weeks.⁸ In a study of mixed headache types, patients who responded to the block reported an average pain decrease of about 83 percent, and that benefit persisted for a mean of roughly six and a half weeks.⁹

For occipital neuralgia specifically, the numbers look even more encouraging. A prospective study of 44 patients found that over 95 percent had satisfactory results lasting at least six months. Pain scores dropped from above seven out of ten to about two, and that level held at the six-month follow-up with no significant creep back upward.¹⁰ A CT-guided approach in another series reported an average relief duration of about nine months among the patients who responded.¹¹

Why the relief outlasts the drug is a question researchers are still working out. Part of the explanation involves the corticosteroid often mixed into the injection. Steroids block certain pain-transmitting nerve fibers and are thought to reduce the exaggerated pain sensitivity that develops during chronic headache states.¹² But even that doesn’t fully explain weeks of relief from an injection whose pharmacological action should last a day or two. The prevailing idea is that the block interrupts a self-reinforcing cycle of nerve sensitization, essentially giving the overexcited pain pathways a chance to reset.

Different Headache Types, Different Results

The block is used for a wide variety of headache conditions, and the speed and quality of relief are not identical across all of them.

For acute migraine, the evidence is strongest for pain reduction in the 30- to 60-minute window, as the meta-analyses described above consistently show. But whether the block provides sustained headache relief past that initial window in acute migraine is less clear. That same acute migraine meta-analysis found no significant advantage for sustained headache relief or reduced need for rescue medication.¹ This makes the block useful for breaking an acute attack but not necessarily a standalone long-term fix for migraine.

For cervicogenic headache, which originates from structures in the neck, a double-blind randomized trial found that nerve-stimulator-guided occipital nerve blocks cut pain scores and associated symptoms like nausea and light sensitivity by roughly half from baseline, with benefits persisting at two weeks.¹³

For cluster headache, the block is used more as a bridge therapy while preventive medications are ramping up. A study of 14 cluster headache patients treated with greater occipital nerve blocks found significant decreases in headache intensity, frequency, and duration in the week after the block compared to the week before. The mean number of headache-free days was about 13, though responses varied widely, with roughly a third of patients seeing no benefit at all.¹⁴ A case report documented complete cessation of a cluster attack after a single injection with a steroid.¹⁵

What Gets Injected and How That Changes the Timeline

The two most common local anesthetics used are lidocaine and bupivacaine. Lidocaine kicks in faster (within minutes) but wears off sooner, while bupivacaine has a slightly slower onset but lasts longer. A study comparing the two agents found that lidocaine appeared to provide faster initial relief, but regression analysis suggested that your baseline pain severity, not the drug choice, was the main factor determining how well you respond overall.¹⁶ In practice, many clinicians mix a local anesthetic with a corticosteroid like triamcinolone, methylprednisolone, or dexamethasone. The anesthetic handles the immediate pain relief while the steroid extends the benefit over weeks.

The steroid component is also worth considering in a more targeted way. A randomized controlled trial looked at adding dexamethasone to a scalp nerve block and found that the steroid group maintained analgesia for a median of about 11 hours, compared to about seven hours in the group without it.¹⁷ That’s a meaningful difference in the acute period, and the steroid’s anti-inflammatory effects likely contribute to the longer-term benefit that plays out over days and weeks.

The Injection Technique Matters More Than You’d Think

Occipital nerve blocks can be performed using simple anatomical landmarks or with the help of ultrasound guidance. The landmark method is faster and doesn’t require special equipment. The provider feels for certain bony and muscular reference points at the back of the head and injects in that general area, relying on the spread of the anesthetic to reach the nerve. It works much of the time, but because of the anatomical variability mentioned earlier, accuracy can vary.

Ultrasound guidance lets the provider see the nerve and surrounding blood vessels in real time. A trial comparing the two approaches in chronic migraine patients found that the ultrasound-guided group had significantly lower pain scores and fewer attacks at one month. At three months, average pain scores in the ultrasound group had dropped from about 9.5 to about 4.7 out of ten, while the landmark group went from about 9.5 to 7.¹⁸ Another study found that the ultrasound approach produced a larger pain reduction both at 30 minutes and at four weeks.¹⁹

Where along the nerve the injection is placed also matters. A review noted that blocks performed closer to where the nerve exits the spine (proximal blocks) and blocks performed higher up near the back of the skull (distal blocks) produce similar immediate pain relief, but the proximal approach tends to give longer-lasting results at one to two months.⁴ If you’ve had a block that seemed to work initially but faded quickly, asking about a different injection site or requesting ultrasound guidance on a repeat attempt are reasonable conversations to have with your provider.

Side Effects and What to Expect Afterward

The procedure is generally safe, but side effects do occur. A large audit of over 1,500 injections documented the complication landscape in useful detail. Immediate complications happened in about 2 percent of cases, with the most common being fainting or near-fainting, likely from the needle stick itself or from the patient’s vasovagal response. A small number of patients reported odd sensations in the face or tongue immediately after the injection, probably because the medication’s effects traveled along connected nerve pathways in the upper spinal cord.²⁰

Delayed effects were more common than immediate ones. In the same audit, about 10 percent of patients who provided follow-up data reported a delayed issue, most often lingering tenderness at the injection site. Serious side effects were rare: four cases of temporary hair loss in the area, two seizures in patients who already had epilepsy, one allergic reaction, and one eye-related complication.²⁰ Another study looking specifically at lidocaine injections found a 9 percent overall adverse effect rate, with higher rates in older patients (age 70 and above) and in those receiving bilateral blocks. Using a lower concentration of lidocaine appeared safer.²¹

Hair loss at the injection site is the side effect that seems to alarm patients the most when they hear about it, but it’s worth noting just how infrequent it is: four cases out of nearly 1,600 injections. And the hair typically grows back. The injection-site soreness is much more common and usually resolves within a day or two.

When Relief Takes Days Instead of Minutes

In pediatric patients, the timeline can look quite different. A study of 40 children and adolescents with chronic primary headaches found that the onset of benefit ranged from the same day all the way out to 14 days, with a mean onset around five days. When the block did work, benefits lasted an average of about five and a half weeks. Overall, about 53 percent of the young patients benefitted, and that proportion was higher for chronic migraine (62 percent) than for new daily persistent headache (33 percent).²² The delayed onset in kids may reflect differences in how developing nervous systems respond to the block, or it may simply be that younger patients have a harder time noticing and reporting gradual improvements in real time.

Adults can also experience a delayed response, particularly when the block is being used preventively rather than to break an acute headache. In those cases, the local anesthetic effect may kick in within 30 minutes, produce some initial relief, then wear off, and a broader preventive benefit may emerge over the following days as the steroid component takes full effect and the sensitized nerve pathways calm down. Patients who are told to expect instant relief may mistakenly conclude the procedure failed if that initial benefit wears off before the longer-term benefit has had time to develop.

Who Tends to Respond Best

Not everyone gets meaningful relief. In the mixed-headache-type study mentioned earlier, about 22 percent of patients did not respond to the block at all.⁹ So while the odds are in your favor, a failed block is not unusual. A multi-center study evaluating predictors of outcome for occipital nerve procedures found that patients whose headache began after a traumatic event had notably higher success rates. Interestingly, the same study found that using smaller volumes of anesthetic for diagnostic blocks was associated with better outcomes, possibly because a smaller volume more precisely identifies whether the occipital nerve is actually the pain generator.²³

Medication overuse is another factor that shapes whether and how quickly the block works. The mixed-headache study noted that overuse of acute headache medications influenced failure rates. If you’ve been taking painkillers daily for months, the underlying sensitization of your pain pathways may be harder to interrupt with a single injection. In the pediatric study, however, medication overuse did not predict whether the child responded, which suggests the relationship between overuse and block failure may differ by age group.²²

The type of headache matters too. Occipital neuralgia, which directly involves the nerve being blocked, unsurprisingly responds the most reliably and for the longest duration. Migraine responds well in most studies but with more variability, and cluster headache responses are the most hit-or-miss. If your provider suggests a repeat block or a different technique after a partial first response, that’s standard practice and not a sign that you’re treatment-resistant. Some patients need two or three rounds, spaced weeks apart, before hitting a cumulative benefit that sticks.

1
PubMed Central. Influence of greater occipital nerve block on the relief of acute migraine: A meta-analysis
2
PubMed. Effectiveness of Peripheral Nerve Blocks for the Treatment of Primary Headache Disorders: A Systematic Review and Meta-Analysis
3
PubMed. The effectiveness of greater occipital nerve blockade in treating acute migraine-related headaches in emergency departments
4
PubMed Central. Occipital nerve block for headaches: a narrative review
5
PubMed. Expert consensus recommendations for the performance of peripheral nerve blocks for headaches–a narrative review
6
PubMed Central. Topographical study of the trapezius muscle, greater occipital nerve, and occipital artery for facilitating blockade of the greater occipital nerve
7
Journal of Neurology, Neurosurgery & Psychiatry. Greater occipital nerve block modulates nociceptive signals within the trigeminocervical complex
8
Cephalalgia Reports. Role of greater occipital nerve block for preventive treatment of chronic migraine: A critical review
9
PubMed. Occipital nerve blocks: effect of symptomatic medication: overuse and headache type on failure rate
10
PubMed Central. Effectiveness of treatment of occipital neuralgia using the nerve block technique: a prospective analysis of 44 patients
11
PubMed. A simplified CT-guided approach for greater occipital nerve infiltration in the management of occipital neuralgia
12
Neurology India. Role of Greater Occipital Nerve Block in Headache Disorders
13
PubMed. Occipital nerve blockade for cervicogenic headache: a double-blind randomized controlled clinical trial
14
PubMed. Greater occipital nerve blockade for cluster headache
15
PubMed Central. Acute Treatment of Cluster Headache with Great Occipital Nerve Blockade
16
PubMed. Comparison of the efficacy of lidocaine and bupivacaine in GON blockade for prophylaxis of chronic migraine
17
PubMed Central. Efficacy of Dexamethasone as an Adjuvant for Scalp Nerve Blocks to Prolong Analgesia: A Prospective, Double-Blind, Randomized Controlled Study
18
PubMed Central. Comparison of two methods of greater occipital nerve block in patients with chronic migraine: ultrasound-guided and landmark-based techniques
19
The Clinical Journal of Pain. Comparative Effectiveness of Landmark-guided Greater Occipital Nerve (GON) Block at the Superior Nuchal Line Versus Ultrasound-guided GON Block at the Level of C2
20
Annals of Headache Medicine. Greater Occipital Nerve Blockade: Safety, Adverse Effects, and Patient Outcomes In 1577 Injections
21
PubMed Central. Adverse effect profile of lidocaine injections for occipital nerve block in occipital neuralgia
22
PubMed Central. Outcomes of greater occipital nerve injections in pediatric patients with chronic primary headache disorders
23
Pain Medicine. Occipital Nerve Pulsed Radiofrequency Treatment: A Multi-Center Study Evaluating Predictors of Outcome